Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Parry–Romberg Syndrome can involve the brain even without obvious symptoms, and a new diagnostic framework is suggested for early detection.

Nanocarriers can improve drug delivery through the skin by overcoming barriers.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Botulinum toxin A helped a patient recover from dissecting folliculitis when antibiotics failed.

Botulinum and tetanus neurotoxins are better understood now, with updated information on their effects and treatment.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Botulinum toxin is used to treat many medical conditions beyond cosmetic purposes.

Botulinum toxin, once seen as a poison, is now used to treat medical conditions and is unlikely to be an effective biological weapon.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

TCDD changes skin cell growth and keratin production in mice.

Botulinum toxin is effective for medical and cosmetic uses but requires careful handling to avoid serious side effects.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

Botulinum toxin Type A helps reduce hypertrophic scars and is generally safe.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Botulinum toxin-A reduces wound and skin graft contraction.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.